Global Veterinary Vaccines Market 2017-2021
About Veterinary Vaccines
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.
Technavio’s analysts forecast the global veterinary vaccines market to grow at a CAGR of 4.81% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global veterinary vaccines market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Veterinary Vaccines Market 2017-2021
Technavio recognizes the following companies as the key players in the global veterinary vaccines market: Elanco, Merck, Merial, and Zoetis.
Other Prominent Vendors in the market are: Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, and Virbac.
Commenting on the report, an analyst from Technavio’s team said: “One trend in market is inorganic growth strategies. The animal care market has been witnessing an increase in strategic alliances and acquisitions among vendors. The vendors undertake inorganic growth strategies such as acquisitions and/or partnerships to expand their product portfolio and to improve their penetration in the emerging markets.”
According to the report, one driver in market is advances in technology. The advances in technology have improved the overall pharmacokinetics and dynamics of vaccines. The use of cell line culture in the manufacture of viral vaccinations has increased, which have improved the quality of vaccinations. For instance, GE Healthcare and Valneva have collaborated to produce optimized cell culture for vaccine production. The advances in the purification process of vaccination have improved the product quality and reduced the cost. The development of new ligands for affinity chromatography, like lectin-affinity chromatography for downstream processing of cell culture, helped Sigma-Aldrich derive the influenza A viruses. These advances in technology are adding to the vaccine sales globally. For instance, the launch of various mobile applications such as PocketVet and Pet First Aid, help the owners get reminders regarding vaccines, which increases the awareness and boosts the usage of vaccines.
Further, the report states that one challenges in market is manufacturing and storage issues. Vaccines involve a complex network of processes, ranging from manufacturing to delivery. The cost-intensive manufacturing issues associated with vaccines get quadrupled with strict regulatory laws. The protocol set by the FAO for manufacturing animal vaccines involve stringent processes like Master Seed and Master Stock analysis. These processes are important in producing quality vaccines as they involve the analysis of microbes, which are used in vaccines manufacturing, followed by sterilization and storage processes. All these processes need to fulfill the required regulatory limits to get the desired product with safety and efficacy profiles. The downstream processing of these vaccines contributes to a major cost of production and is very crucial to conserve the purity of the product.
Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, and Virbac.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook